| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alcohol and bone: review of dose effects and mechanisms
|
Maurel, D. B.
|
|
2011
|
23 |
1 |
p. 1-16
|
artikel
|
| 2 |
Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials
|
Barrett-Connor, E.
|
|
2011
|
23 |
1 |
p. 233-245
|
artikel
|
| 3 |
A meta-analysis of brief high-impact exercises for enhancing bone health in premenopausal women
|
Babatunde, O. O.
|
|
2011
|
23 |
1 |
p. 109-119
|
artikel
|
| 4 |
A reappraisal of generic bisphosphonates in osteoporosis
|
Kanis, J. A.
|
|
2011
|
23 |
1 |
p. 213-221
|
artikel
|
| 5 |
Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)
|
Bruyère, O.
|
|
2011
|
23 |
1 |
p. 193-199
|
artikel
|
| 6 |
Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS)
|
Ferrar, L.
|
|
2011
|
23 |
1 |
p. 59-65
|
artikel
|
| 7 |
Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys
|
Jerome, C.
|
|
2011
|
23 |
1 |
p. 339-349
|
artikel
|
| 8 |
Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis
|
Knopp-Sihota, J. A.
|
|
2011
|
23 |
1 |
p. 17-38
|
artikel
|
| 9 |
Combination of texture analysis and bone mineral density improves the prediction of fracture load in human femurs
|
Le Corroller, T.
|
|
2011
|
23 |
1 |
p. 163-169
|
artikel
|
| 10 |
Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study
|
Cooper, M. S.
|
|
2011
|
23 |
1 |
p. 97-107
|
artikel
|
| 11 |
Deletion of estrogen receptor beta accelerates early stage of bone healing in a mouse osteotomy model
|
He, Y.-X.
|
|
2011
|
23 |
1 |
p. 377-389
|
artikel
|
| 12 |
Effect of monthly ibandronate on hip structural geometry in men with low bone density
|
Genant, H. K.
|
|
2011
|
23 |
1 |
p. 257-265
|
artikel
|
| 13 |
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis
|
Rizzoli, R.
|
|
2011
|
23 |
1 |
p. 305-315
|
artikel
|
| 14 |
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
|
McClung, M. R.
|
|
2011
|
23 |
1 |
p. 267-276
|
artikel
|
| 15 |
Erratum to: Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis
|
Rhee, C. W.
|
|
2011
|
23 |
1 |
p. 255
|
artikel
|
| 16 |
Excess body fat is associated with higher risk of vertebral deformities in older women but not in men: a cross-sectional study
|
Laslett, L. L.
|
|
2011
|
23 |
1 |
p. 67-74
|
artikel
|
| 17 |
Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
|
Freemantle, N.
|
|
2011
|
23 |
1 |
p. 317-326
|
artikel
|
| 18 |
Fracture risk assessment without bone density measurement in routine clinical practice
|
Leslie, W. D.
|
|
2011
|
23 |
1 |
p. 75-85
|
artikel
|
| 19 |
GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates
|
Hadji, P.
|
|
2011
|
23 |
1 |
p. 223-231
|
artikel
|
| 20 |
High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice
|
Leslie, W. D.
|
|
2011
|
23 |
1 |
p. 391-397
|
artikel
|
| 21 |
Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial
|
Jaglal, S. B.
|
|
2011
|
23 |
1 |
p. 87-95
|
artikel
|
| 22 |
Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
|
Watts, N. B.
|
|
2011
|
23 |
1 |
p. 327-337
|
artikel
|
| 23 |
Meta-analysis of gene-based genome-wide association studies of bone mineral density in Chinese and European subjects
|
Cheung, C.-L.
|
|
2011
|
23 |
1 |
p. 131-142
|
artikel
|
| 24 |
Pattern of use of DXA scans in men: a cross-sectional, population-based study
|
Frost, M.
|
|
2011
|
23 |
1 |
p. 183-191
|
artikel
|
| 25 |
Physical activity, calcium intake and childhood bone mineral: a population-based cross-sectional study
|
Harvey, N. C.
|
|
2011
|
23 |
1 |
p. 121-130
|
artikel
|
| 26 |
Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture Trial
|
Wustrack, R.
|
|
2011
|
23 |
1 |
p. 53-58
|
artikel
|
| 27 |
Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density
|
Cohen, A.
|
|
2011
|
23 |
1 |
p. 171-182
|
artikel
|
| 28 |
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis
|
Moayyeri, A.
|
|
2011
|
23 |
1 |
p. 143-153
|
artikel
|
| 29 |
Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women
|
Srinivasan, B.
|
|
2011
|
23 |
1 |
p. 155-162
|
artikel
|
| 30 |
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists
|
Bradbury, L. A.
|
|
2011
|
23 |
1 |
p. 285-294
|
artikel
|
| 31 |
Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies
|
Wu, Q.
|
|
2011
|
23 |
1 |
p. 365-375
|
artikel
|
| 32 |
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study
|
Silverman, S. L.
|
|
2011
|
23 |
1 |
p. 351-363
|
artikel
|
| 33 |
The effect of exercise on pQCT parameters of bone structure and strength in postmenopausal women—a systematic review and meta-analysis of randomized controlled trials
|
Polidoulis, I.
|
|
2011
|
23 |
1 |
p. 39-51
|
artikel
|
| 34 |
The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial
|
Grimnes, G.
|
|
2011
|
23 |
1 |
p. 201-211
|
artikel
|
| 35 |
The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years
|
Middleton, E. T.
|
|
2011
|
23 |
1 |
p. 295-303
|
artikel
|
| 36 |
Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis
|
Rhee, C. W.
|
|
2011
|
23 |
1 |
p. 247-254
|
artikel
|
| 37 |
Validation of cross-sectional studies with long-term longitudinal studies
|
Cure-Cure, C.
|
|
2011
|
23 |
1 |
p. 399
|
artikel
|
| 38 |
Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors
|
Roux, C.
|
|
2011
|
23 |
1 |
p. 277-284
|
artikel
|
Tijdschrift beschrijving